myristic acids

Preferred Label : myristic acids;

MeSH definition : 14-carbon saturated monocarboxylic acids.;

MeSH synonym : tetradecanoic acids; acids, myristic; acids, tetradecanoic;

Is substance : O;

Details

Origin ID

D009227;

UMLS CUI

C0027139;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Myristic acid [FMA entity]
- Myristic acid (substance) [SNOMED CT concept]
- myristic acid [Substance BNPC]
- myristic acid [SNOMED Notion]
- myristic acid [Artificial nutrition thesaurus concept]
False automatic mappings
- Myristic Acid [NCIt concept]
Record concept(s)
- myristic acids [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1-monomyristin [MeSH Supplementary Concept]
- 1-myristylpicolinium [MeSH Supplementary Concept]
- 10,12-tetradecadienoic acid [MeSH Supplementary Concept]
- 10-propoxydecanoic acid [MeSH Supplementary Concept]
- 13-methyltetradecanoic acid [MeSH Supplementary Concept]
- 14-(iodophenyl)-3-methyltetradecanoic acid [MeSH Supplementary Concept]
- 2,4-dimethyltetradecanoic acid [MeSH Supplementary Concept]
- 2-bromomyristic acid [MeSH Supplementary Concept]
- 2-deoxy-2-(3-hydroxytetradecanoyl)aminoglucose 6-phosphate [MeSH Supplementary Concept]
- 2-methoxytetradecanoic acid [MeSH Supplementary Concept]
- 3-hydroxy-4-methyltetradecanoic acid [MeSH Supplementary Concept]
- 4,6-dihydroxy-4,6,8,10-tetraethyltetradec-2,7,11-trienoic acid [MeSH Supplementary Concept]
- 4,6-dihydroxy-8-methyl-4,6,10-triethyltetradeca-2,7,11-trienoic acid [MeSH Supplementary Concept]
- 5,6-dichloromyristic acid [MeSH Supplementary Concept]
- 8,8-difluoromyristic acid [MeSH Supplementary Concept]
- N-myristoyl-2-aminopropane [MeSH Supplementary Concept]
- N-myristoyl-alaninol [MeSH Supplementary Concept]
- N-myristoylethanolamine [MeSH Supplementary Concept]
- N-myristoylglycine [MeSH Supplementary Concept]
- UDP-3-O-(3-hydroxymyristoyl)-N-acetylglucosamine [MeSH Supplementary Concept]
- alpha-hydroxymyristic acid [MeSH Supplementary Concept]
- beta-hydroxymyristic acid [MeSH Supplementary Concept]
- methyl tetradecanoate [MeSH Supplementary Concept]
- myristoyl tryptamine [MeSH Supplementary Concept]
- myristoylcarnitine [MeSH Supplementary Concept]
- myristoylmethionine [MeSH Supplementary Concept]
- myristyldimethylamine oxide [MeSH Supplementary Concept]
- peroxytetradecanoic acid [MeSH Supplementary Concept]
- triethyleneglycol mono n-tetradecyl ether [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients